Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 343154, 12 pages
http://dx.doi.org/10.1155/2014/343154
Review Article

Protein Redox Modification as a Cellular Defense Mechanism against Tissue Ischemic Injury

Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, RES-314E, Fort Worth, TX 76107, USA

Received 3 March 2014; Accepted 16 April 2014; Published 5 May 2014

Academic Editor: Jianping Jin

Copyright © 2014 Liang-Jun Yan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Groeger, C. Quiney, and T. G. Cotter, “Hydrogen peroxide as a cell-survival signaling molecule,” Antioxidants and Redox Signaling, vol. 11, no. 11, pp. 2655–2671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Knoefler, M. Thamsen, M. Koniczek, N. J. Niemuth, A. K. Diederich, and U. Jakob, “Quantitative in vivo redox sensors uncover oxidative stress as an early event in life,” Molecular Cell, vol. 47, pp. 767–776, 2012. View at Google Scholar
  3. G. Groeger, F. Doonan, T. G. Cotter, and M. Donovan, “Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina,” Investigative Ophthalmology & Visual Science, vol. 53, pp. 6645–6654, 2012. View at Google Scholar
  4. E. Bevilacqua, S. Z. Gomes, A. R. Lorenzon, M. S. Hoshida, and A. M. Amarante-Paffaro, “NADPH oxidase as an important source of reactive oxygen species at the mouse maternal-fetal interface: putative biological roles,” Reproductive BioMedicine Online, vol. 25, pp. 31–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Müller and N. S. Dhalla, “Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic-reperfused heart,” Current Cardiology Reviews, vol. 6, no. 4, pp. 255–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Wiegand, W. Liao, C. Busch et al., “Respiratory chain inhibition induces tolerance to focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 11, pp. 1229–1237, 1999. View at Google Scholar · View at Scopus
  7. F. Bosetti, G. Yu, R. Zucchi, S. Ronca-Testoni, and G. Solaini, “Myocardial ischemic preconditioning and mitochondrial F1F0-ATPase activity,” Molecular and Cellular Biochemistry, vol. 215, no. 1-2, pp. 31–37, 2000. View at Google Scholar · View at Scopus
  8. K. Kitagawa, “CREB and cAMP response element-mediated gene expression in the ischemic brain,” FEBS Journal, vol. 274, no. 13, pp. 3210–3217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kitagawa, “Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress,” Journal of Neuroscience Research, vol. 90, no. 5, pp. 1043–1054, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. W. Yang, H. J. Ahn, H. J. Han et al., “Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney,” Transplantation, vol. 72, no. 11, pp. 1753–1759, 2001. View at Google Scholar · View at Scopus
  11. T. Ravingerová, “Intrinsic defensive mechanisms in the heart: a potential novel approach to cardiac protection against ischemic injury,” General Physiology and Biophysics, vol. 26, no. 1, pp. 3–13, 2007. View at Google Scholar · View at Scopus
  12. R. A. Stetler, F. Zhang, C. Liu, and J. Chen, “Chapter 9 Ischemic tolerance as an active and intrinsic neuroprotective mechanism,” Handbook of Clinical Neurology, vol. 92, pp. 171–195, 2009. View at Google Scholar · View at Scopus
  13. D. Della-Morte, F. Guadagni, R. Palmirotta et al., “Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning,” Pharmacogenomics, vol. 13, pp. 1741–1757, 2012. View at Google Scholar
  14. G. Lebuffe, P. T. Schumacker, Z. Shao, T. Anderson, H. Iwase, and T. L. Vanden Hoek, “ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 1, pp. H299–H308, 2003. View at Google Scholar · View at Scopus
  15. V. Fernández, G. Tapia, P. Varela et al., “Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats,” Free Radical Biology and Medicine, vol. 44, no. 9, pp. 1724–1731, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Zucchi, G. Yu, P. Galbani, M. Mariani, G. Ronca, and S. Ronca-Testoni, “Sulfhydryl redox state affects susceptibility to ischemia and sarcoplasmic reticulum Ca2+ release in rat heart implications for ischemic preconditioning,” Circulation Research, vol. 83, no. 9, pp. 908–915, 1998. View at Google Scholar · View at Scopus
  17. T. Mori, H. Muramatsu, T. Matsui, A. Mckee, and T. Asano, “Possible role of the superoxide anion in the development of neuronal tolerance following ischaemic preconditioning in rats,” Neuropathology and Applied Neurobiology, vol. 26, no. 1, pp. 31–40, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Bhagatte, D. Lodwick, and N. Storey, “Mitochondrial ROS production and subsequent ERK phosphorylation are necessary for temperature preconditioning of isolated ventricular myocytes,” Cell Death and Disease, vol. 3, article e345, 2012. View at Google Scholar
  19. L. Zuo, W. J. Roberts, R. C. Tolomello, and A. T. Goins, “Ischemic and hypoxic preconditioning protect cardiac muscles via intracellular ROS signaling,” Frontiers in Biology, vol. 8, pp. 305–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Jiang, Y. Zhang, and G. J. Dusting, “NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair,” Pharmacological Reviews, vol. 63, no. 1, pp. 218–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Hochgräfe, J. Mostertz, D. Pöther, D. Becher, J. D. Helmann, and M. Hecker, “S-cysteinylation is a general mechanism for thiol protection of Bacillus subtilis proteins after oxidative stress,” The Journal of Biological Chemistry, vol. 282, no. 36, pp. 25961–25985, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. T. Hancock, “The role of redox mechanisms in cell signalling,” Molecular Biotechnology, vol. 43, no. 2, pp. 162–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Shao, S. Oka, C. D. Brady, J. Haendeler, P. Eaton, and J. Sadoshima, “Redox modification of cell signaling in the cardiovascular system,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 3, pp. 550–558, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Lizama-Manibusan and B. McLaughlin, “Redox modification of proteins as essential mediators of CNS autophagy and mitophagy,” FEBS Letters, vol. 587, pp. 2291–2298, 2013. View at Google Scholar
  25. N. Gould, P. T. Doulias, M. Tenopoulou, K. Raju, and H. Ischiropoulos, “Regulation of protein function and signaling by reversible cysteine S-nitrosylation,” The Journal of Biological Chemistry, vol. 288, pp. 26473–26479, 2013. View at Google Scholar
  26. L. J. Yan, “Positive oxidative stress in aging and aging-related disease tolerance,” Redox Biology, vol. 2, pp. 165–169, 2014. View at Google Scholar
  27. M. J. Jackson, S. Papa, J. Bolaños et al., “Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function,” Molecular Aspects of Medicine, vol. 23, no. 1–3, pp. 209–285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. L. J. Yan, R. L. Levine, and R. S. Sohal, “Oxidative damage during aging targets mitochondrial aconitase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, pp. 11168–11172, 1997. View at Google Scholar
  30. L. Yan, J. K. Lodge, M. G. Traber, and L. Packer, “Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins,” Archives of Biochemistry and Biophysics, vol. 339, no. 1, pp. 165–171, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Yan and R. S. Sohal, “Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damamge to specific mitochondrial proteins,” Free Radical Biology and Medicine, vol. 29, no. 11, pp. 1143–1150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Yan and R. S. Sohal, “Mitochondrial adenine nucleotide translocase is modified oxidatively during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 22, pp. 12896–12901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. L. J. Yan, “Analysis of oxidative modification of proteins,” Current Protocols in Protein Science, Chapter 14, Unit 14 14, 2009.
  34. R. Radi, “Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects,” Accounts of Chemical Research, vol. 46, pp. 550–559, 2013. View at Google Scholar
  35. K. G. Reddie and K. S. Carroll, “Expanding the functional diversity of proteins through cysteine oxidation,” Current Opinion in Chemical Biology, vol. 12, no. 6, pp. 746–754, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. B. Wall, J. Y. Oh, A. R. Diers, and A. Landar, “Oxidative modification of proteins: an emerging mechanism of cell signaling,” Frontiers in Physiology, vol. 3, article 369, 2012. View at Google Scholar
  37. H. J. Forman, J. M. Fukuto, and M. Torres, “Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers,” The American Journal of Physiology—Cell Physiology, vol. 287, no. 2, pp. C246–C256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. J. Yan, N. Sumien, N. Thangthaeng, and M. J. Forster, “Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide,” Free Radical Research, vol. 47, pp. 123–133, 2013. View at Google Scholar
  39. Y. M. Janssen-Heininger, J. D. Nolin, S. M. Hoffman et al., “Emerging mechanisms of glutathione-dependent chemistry in biology and disease,” Journal of Cellular Biochemistry, vol. 114, pp. 1962–1968, 2013. View at Google Scholar
  40. L. B. Poole, “Formation and functions of protein sulfenic acids,” Current Protocols in Toxicology, Chapter 17, Unit 17 11, 2004.
  41. T. Hoshi and S. H. Heinemann, “Regulation of cell function by methionine oxidation and reduction,” The Journal of Physiology, vol. 531, no. 1, pp. 1–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Boschi-Muller, A. Gand, and G. Branlant, “The methionine sulfoxide reductases: catalysis and substrate specificities,” Archives of Biochemistry and Biophysics, vol. 474, no. 2, pp. 266–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. L. Levine, J. Moskovitz, and E. R. Stadtman, “Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation,” IUBMB Life, vol. 50, no. 4-5, pp. 301–307, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Moskovitz, S. Bar-Noy, W. M. Williams, J. Requena, B. S. Berlett, and E. R. Stadtman, “Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 12920–12925, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Zhao, J. Sun, A. M. Deschamps et al., “Myristoylated methionine sulfoxide reductase A protects the heart from ischemia-reperfusion injury,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 301, no. 4, pp. H1513–H1518, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. O. Yermolaieva, R. Xu, C. Schinstock et al., “Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 5, pp. 1159–1164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. I. Kim, S. H. Choi, K. J. Jung, E. Lee, H. Y. Kim, and K. M. Park, “Protective role of methionine sulfoxide reductase A against ischemia/reperfusion injury in mouse kidney and its involvement in the regulation of trans-sulfuration pathway,” Antioxidants & Redox Signaling, vol. 18, pp. 2241–2250, 2013. View at Google Scholar
  48. L. I. Leichert, F. Gehrke, H. V. Gudiseva et al., “Quantifying changes in the thiol redox proteome upon oxidative stress in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 24, pp. 8197–8202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Chull An, S. Sik Lee, E. Mi Lee, S. Gon Wi, W. Park, and B. Yeoup Chung, “Global analysis of disulfide bond proteins in Pseudomonas aeruginosa exposed to hydrogen peroxide and gamma rays,” International Journal of Radiation Biology, vol. 86, no. 5, pp. 400–408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. T. E. Danciu and M. Whitman, “Oxidative stress drives disulfide bond formation between basic helix-loop-helix transcription factors,” Journal of Cellular Biochemistry, vol. 109, no. 2, pp. 417–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. C. Cumming, N. L. Andon, P. A. Haynes, M. Park, W. H. Fischer, and D. Schubert, “Protein disulfide bond formation in the cytoplasm during oxidative stress,” The Journal of Biological Chemistry, vol. 279, no. 21, pp. 21749–21758, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Sommer and R. R. Traut, “Diagonal polyacrylamide dodecyl sulfate gel electrophoresis for the identification of ribosomal proteins crosslinked with methyl 4 mercaptobutyrimidate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 10, pp. 3946–3950, 1974. View at Google Scholar · View at Scopus
  53. C. M. Cremers and U. Jakob, “Oxidant sensing by reversible disulfide bond formation,” The Journal of Biological Chemistry, vol. 288, pp. 26489–26496, 2013. View at Google Scholar
  54. A. Pastore and F. Piemonte, “S-glutathionylation signaling in cell biology: progress and prospects,” European Journal of Pharmaceutical Sciences, vol. 46, pp. 279–292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Muller, J. H. Hoffmann, H. E. Meyer, F. Narberhaus, U. Jakob, and L. I. Leichert, “Nonnative disulfide bond formation activates the sigma32-dependent heat shock response in Escherichia coli,” Journal of Bacteriology, vol. 195, pp. 2807–2816, 2013. View at Google Scholar
  56. P. Venditti, L. di Stefano, and S. di Meo, “Mitochondrial metabolism of reactive oxygen species,” Mitochondrion, vol. 13, pp. 71–82, 2013. View at Google Scholar
  57. J. St-Pierre, J. A. Buckingham, S. J. Roebuck, and M. D. Brand, “Topology of superoxide production from different sites in the mitochondrial electron transport chain,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 44784–44790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Miwa, J. St-Pierre, L. Partridge, and M. D. Brand, “Superoxide and hydrogen peroxide production by Drosophila mitochondria,” Free Radical Biology and Medicine, vol. 35, no. 8, pp. 938–948, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Drose and U. Brandt, “Molecular mechanisms of superoxide production by the mitochondrial respiratory chain,” Advances in Experimental Medicine and Biology, vol. 748, pp. 145–169, 2012. View at Google Scholar
  60. I. Siebels and S. Drose, “Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates,” Biochimica et Biophysica Acta, vol. 1827, pp. 1156–1164, 2013. View at Google Scholar
  61. L. J. Yan, N. Thangthaeng, N. Sumien, and M. J. Forster, “Serum Dihydrolipoamide Dehydrogenase is a Labile enzyme,” Journal of Biochemical and Pharmacological Research, vol. 1, pp. 30–42, 2013. View at Google Scholar
  62. A. A. Starkov, G. Fiskum, C. Chinopoulos et al., “Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7779–7788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Ambrus, L. Tretter, and V. Adam-Vizi, “Inhibition of the alpha-ketoglutarate dehydrogenase-mediated reactive oxygen species generation by lipoic acid,” Journal of Neurochemistry, vol. 109, supplement 1, pp. 222–229, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Ambrus, B. Torocsik, L. Tretter, O. Ozohanics, and V. Adam-Vizi, “Stimulation of reactive oxygen species generation by disease-causing mutations of lipoamide dehydrogenase,” Human Molecular Genetics, vol. 20, no. 15, pp. 2984–2995, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Ambrus and V. Adam-Vizi, “Molecular dynamics study of the structural basis of dysfunction and the modulation of reactive oxygen species generation by pathogenic mutants of human dihydrolipoamide dehydrogenase,” Archives of Biochemistry and Biophysics, vol. 538, pp. 145–155, 2013. View at Google Scholar
  66. A. Manea, “NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology,” Cell and Tissue Research, vol. 342, no. 3, pp. 325–339, 2010. View at Google Scholar · View at Scopus
  67. J. Bylund, K. L. Brown, C. Movitz, C. Dahlgren, and A. Karlsson, “Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?” Free Radical Biology and Medicine, vol. 49, no. 12, pp. 1834–1845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Harrison, “Physiological roles of xanthine oxidoreductase,” Drug Metabolism Reviews, vol. 36, no. 2, pp. 363–375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Agarwal, A. Banerjee, and U. C. Banerjee, “Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling,” Critical Reviews in Biotechnology, vol. 31, no. 3, pp. 264–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. L. Mandelker, “Introduction to oxidative stress and mitochondrial dysfunction,” Veterinary Clinics of North America—Small Animal Practice, vol. 38, no. 1, pp. 1–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. C. L. Quinlan, R. L. Goncalves, M. Hey-Mogensen, N. Yadava, V. I. Bunik, and M. D. Brand, “The 2-oxoacid dehydrogenase complexes in mitochondria can produce superoxide/hydrogen peroxide at much higher rates than complex I,” The Journal of Biological Chemistry, 2014. View at Publisher · View at Google Scholar
  72. P. J. Kiley and G. Storz, “Exploiting thiol modifications,” PLoS Biology, vol. 2, no. 11, article e400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. J. F. Turrens, “Superoxide production by the mitochondrial respiratory chain,” Bioscience Reports, vol. 17, no. 1, pp. 3–8, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. J. F. Turrens, A. Alexandre, and A. L. Lehninger, “Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria,” Archives of Biochemistry and Biophysics, vol. 237, no. 2, pp. 408–414, 1985. View at Google Scholar · View at Scopus
  75. B. N. Ames and M. K. Shigenaga, “Oxidants are a major contributor to aging,” Annals of the New York Academy of Sciences, vol. 663, pp. 85–96, 1992. View at Google Scholar · View at Scopus
  76. C. Szabó, H. Ischiropoulos, and R. Radi, “Peroxynitrite: biochemistry, pathophysiology and development of therapeutics,” Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. J. J. Poderoso, “The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide,” Archives of Biochemistry and Biophysics, vol. 484, no. 2, pp. 214–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. R. Radi, A. Cassina, R. Hodara, C. Quijano, and L. Castro, “Peroxynitrite reactions and formation in mitochondria,” Free Radical Biology and Medicine, vol. 33, no. 11, pp. 1451–1464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Alvarez and R. Radi, “Peroxynitrite reactivity with amino acids and proteins,” Amino Acids, vol. 25, no. 3-4, pp. 295–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. L. A. Sena and N. S. Chandel, “Physiological roles of mitochondrial reactive oxygen species,” Molecular Cell, vol. 48, pp. 158–167, 2012. View at Google Scholar
  81. R. J. Mailloux, X. Jin, and W. G. Willmore, “Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions,” Redox Biology, vol. 2, pp. 123–139, 2013. View at Google Scholar
  82. N. Kondo, H. Nakamura, H. Masutani, and J. Yodoi, “Redox regulation of human thioredoxin network,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1881–1890, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. N. L. Malinin, X. Z. West, and T. V. Byzova, “Oxidation as ‘the stress of life’,” Aging, vol. 3, no. 9, pp. 906–910, 2011. View at Google Scholar · View at Scopus
  84. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, pp. 931–947, 2013. View at Google Scholar
  85. A. M. Pickering, L. Vojtovich, J. Tower, and K. J. A Davies, “Oxidative stress adaptation with acute, chronic, and repeated stress,” Free Radical Biology and Medicine, vol. 55, pp. 109–118, 2013. View at Google Scholar
  86. K. J. A. Davies, “Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems,” IUBMB Life, vol. 50, no. 4-5, pp. 279–289, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. I. Milisav, B. Poljsak, and D. Suput, “Adaptive response, evidence of cross-resistance and its potential clinical use,” International Journal of Molecular Sciences, vol. 13, pp. 10771–10806, 2012. View at Google Scholar
  88. V. Calabrese, C. Cornelius, S. Cuzzocrea, I. Iavicoli, E. Rizzarelli, and E. J. Calabrese, “Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity,” Molecular Aspects of Medicine, vol. 32, no. 4–6, pp. 279–304, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Luna-Lopez, V. Y. Gonzalez-Puertos, J. Romero-Ontiveros et al., “A noncanonical NF-kappaB pathway through the p50 subunit regulates Bcl-2 overexpression during an oxidative-conditioning hormesis response,” Free Radical Biology and Medicine, vol. 63, pp. 41–50, 2013. View at Google Scholar
  90. G. Lopez-Martinez and D. A. Hahn, “Early life hormetic treatments decrease irradiation-induced oxidative damage, increase longevity, and enhance sexual performance during old age in the Caribbean fruit fly,” PLoS ONE, vol. 9, Article ID e88128, 2014. View at Google Scholar
  91. M. Ristow and S. Schmeisser, “Extending life span by increasing oxidative stress,” Free Radical Biology and Medicine, vol. 51, supplement 2, pp. 327–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Blanco, I. Lizasoain, T. Sobrino, J. Vivancos, and J. Castillo, “Ischemic preconditioning: a novel target for neuroprotective therapy,” Cerebrovascular Diseases, vol. 21, no. 2, pp. 38–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Shiva, M. N. Sack, J. J. Greer et al., “Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2089–2102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. M. R. Bigdeli, “Neuroprotection caused by hyperoxia preconditioning in animal stroke models,” TheScientificWorldJournal, vol. 11, pp. 403–421, 2011. View at Google Scholar · View at Scopus
  95. Y. Soejima, Q. Hu, P. R. Krafft, M. Fujii, J. Tang, and J. H. Zhang, “Hyperbaric oxygen preconditioning attenuates hyperglycemia-enhanced hemorrhagic transformation by inhibiting matrix metalloproteinases in focal cerebral ischemia in rats,” Experimental Neurology, vol. 247, pp. 737–743, 2013. View at Google Scholar
  96. A. M. Stowe, T. Altay, A. B. Freie, and J. M. Gidday, “Repetitive hypoxia extends endogenous neurovascular protection for stroke,” Annals of Neurology, vol. 69, no. 6, pp. 975–985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. Z. Sedaghat, M. Kadkhodaee, B. Seifi, E. Salehi, A. Najafi, and L. Dargahi, “Remote preconditioning reduces oxidative stress, downregulates cyclo-oxygenase-2 expression and attenuates ischaemia-reperfusion-induced acute kidney injury,” Clinical and Experimental Pharmacology and Physiology, vol. 40, pp. 97–103, 2013. View at Google Scholar
  98. J. Vinten-Johansen, Z. Zhao, A. J. Zatta, H. Kin, M. E. Halkos, and F. Kerendi, “Postconditioning: a new link in nature's armor against myocardial ischemia-reperfusion injury,” Basic Research in Cardiology, vol. 100, no. 4, pp. 295–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. H. Zhao, “The protective effect of ischemic postconditioning against ischemic injury: from the heart to the brain,” Journal of Neuroimmune Pharmacology, vol. 2, no. 4, pp. 313–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. H. Zhao, “Ischemic postconditioning as a novel avenue to protect against brain injury after stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 5, pp. 873–885, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Zhao, C. Ren, X. Chen, and J. Shen, “From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia,” Current Drug Targets, vol. 13, no. 2, pp. 173–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Zhao, R. M. Sapolsky, and G. K. Steinberg, “Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 9, pp. 1114–1121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. D. P. Davis and P. M. Patel, “Ischemic preconditioning in the brain,” Current Opinion in Anaesthesiology, vol. 16, no. 5, pp. 447–452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  104. W. Kwok and K. Aizawa, “Preconditioning of the myocardium by volatile anesthetics,” Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 2, no. 3, pp. 249–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  105. C. Penna, D. Mancardi, R. Rastaldo, and P. Pagliaro, “Cardioprotection: a radical view. Free radicals in pre and postconditioning,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1787, no. 7, pp. 781–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. F. Tullio, C. Angotti, M. G. Perrelli, C. Penna, and P. Pagliaro, “Redox balance and cardioprotection,” Basic Research in Cardiology, vol. 108, article 392, 2013. View at Google Scholar
  107. E. Murphy and C. Steenbergen, “Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury,” Physiological Reviews, vol. 88, no. 2, pp. 581–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. Go and D. P. Jones, “Redox compartmentalization in eukaryotic cells,” Biochimica et Biophysica Acta—General Subjects, vol. 1780, no. 11, pp. 1273–1290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  109. Y. M. Go and D. P. Jones, “Thiol/disulfide redox states in signaling and sensing,” Critical Reviews in Biochemistry and Molecular Biology, vol. 48, pp. 173–181, 2013. View at Google Scholar
  110. S. A. Lipton, Y. Choi, H. Takahashi et al., “Cysteine regulation of protein function—as exemplified by NMDA-receptor modulation,” Trends in Neurosciences, vol. 25, no. 9, pp. 474–480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. N. Brandes, S. Schmitt, and U. Jakob, “Thiol-based redox switches in eukaryotic proteins,” Antioxidants and Redox Signaling, vol. 11, no. 5, pp. 997–1014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Li, P. Sonveaux, Z. N. Rabbani et al., “Regulation of HIF-1α stability through S-nitrosylation,” Molecular Cell, vol. 26, no. 1, pp. 63–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  113. D. E. Fomenko, S. M. Marino, and V. N. Gladyshev, “Functional diversity of cysteine residues in proteins and unique features of catalytic redox-active cysteines in thiol oxidoreductases,” Molecules and Cells, vol. 26, no. 3, pp. 228–235, 2008. View at Google Scholar · View at Scopus
  114. H. J. Forman, J. M. Fukuto, T. Miller, H. Zhang, A. Rinna, and S. Levy, “The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal,” Archives of Biochemistry and Biophysics, vol. 477, no. 2, pp. 183–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  115. L. B. Poole, C. Klomsiri, S. A. Knaggs et al., “Fluorescent and affinity-based tools to detect cysteine sulfenic acid formation in proteins,” Bioconjugate Chemistry, vol. 18, no. 6, pp. 2004–2017, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. S. R. Jaffrey and S. H. Snyder, “The biotin switch method for the detection of S-nitrosylated proteins,” Science's STKE: Signal Transduction Knowledge Environment, vol. 2001, no. 86, article pl1, 2001. View at Google Scholar · View at Scopus
  117. L. J. Yan, L. Liu, and M. J. Forster, “Reversible inactivation of dihydrolipoamide dehydrogenase by Angeli's salt,” Acta Biophysica Sinica, vol. 28, pp. 341–350, 2012. View at Google Scholar
  118. B. Huang and C. Chen, “An ascorbate-dependent artifact that interferes with the interpretation of the biotin switch assay,” Free Radical Biology and Medicine, vol. 41, no. 4, pp. 562–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  119. A. T. Saurin, H. Neubert, J. P. Brennan, and P. Eaton, “Widespread sulfenic acid formation in tissues in response to hydrogen peroxide,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 52, pp. 17982–17987, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. S. W. Aesif, Y. M. W. Janssen-Heininger, and N. L. Reynaert, “Protocols for the detection of s-glutathionylated and s-nitrosylated proteins in situ,” Methods in Enzymology, vol. 474, pp. 289–296, 2010. View at Google Scholar · View at Scopus
  121. J. Guo, M. J. Gaffrey, D. Su et al., “Resin-assisted enrichment of thiols as a general strategy for proteomic profiling of cysteine-based reversible modifications,” Nature Protocols, vol. 9, pp. 64–75, 2014. View at Google Scholar
  122. R. L. Charles, E. Schröder, G. May et al., “Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue,” Molecular and Cellular Proteomics, vol. 6, no. 9, pp. 1473–1484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. C. Klomsiri, K. J. Nelson, E. Bechtold et al., “Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteins,” Methods in Enzymology, vol. 473, pp. 77–94, 2010. View at Google Scholar · View at Scopus
  124. K. Kaiserova, S. Srivastava, J. D. Hoetker et al., “Redox activation of aldose reductase in the ischemic heart,” The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15110–15120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  125. K. Kaiserova, X. Tang, S. Srivastava, and A. Bhatnagar, “Role of nitric oxide in regulating aldose reductase activation in the ischemic heart,” The Journal of Biological Chemistry, vol. 283, no. 14, pp. 9101–9112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  126. I. N. Singh, P. G. Sullivan, and E. D. Hall, “Peroxynitrite-mediated oxidative damage to brain mitochondria: protective effects of peroxynitrite scavengers,” Journal of Neuroscience Research, vol. 85, no. 10, pp. 2216–2223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. E. Kilic, Ü. Kilic, Y. Wang, C. L. Bassetti, H. H. Marti, and D. M. Hermann, “The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia,” The FASEB Journal, vol. 20, no. 8, pp. E307–E314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. X. Yu, G. Jia, G. Gao, S. Wang, Y. Han, and W. Cao, “Neuroprotection of insulin against oxidative stress-induced apoptosis in cultured retinal neurons: involvement of phosphoinositide 3-kinase/Akt signal pathway,” Acta Biochimica et Biophysica Sinica, vol. 38, no. 4, pp. 241–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  129. K. Wetzelberger, S. P. Baba, M. Thirunavukkarasu et al., “Postischemic deactivation of cardiac aldose reductase: role of glutathione S-transferase P and glutaredoxin in regeneration of reduced thiols from sulfenic acids,” The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26135–26148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. M. W. Foster, D. T. Hess, and J. S. Stamler, “Protein S-nitrosylation in health and disease: a current perspective,” Trends in Molecular Medicine, vol. 15, no. 9, pp. 391–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. M. W. Foster, T. J. McMahon, and J. S. Stamler, “S-nitrosylation in health and disease,” Trends in Molecular Medicine, vol. 9, no. 4, pp. 160–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. S. J. Chinta and J. K. Andersen, “Nitrosylation and nitration of mitochondrial complex i in Parkinson's disease,” Free Radical Research, vol. 45, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  133. D. M. Barrett, S. M. Black, H. Todor, R. K. Schmidt-Ullrich, K. S. Dawson, and R. B. Mikkelsen, “Inhibition of protein-tyrosine phosphatases by mild oxidative stresses is dependent on S-nitrosylation,” The Journal of Biological Chemistry, vol. 280, no. 15, pp. 14453–14461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. E. Murphy, M. Kohr, J. Sun, T. Nguyen, and C. Steenbergen, “S-nitrosylation: a radical way to protect the heart,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 3, pp. 568–577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. A. M. Evangelista, M. J. Kohr, and E. Murphy, “S-nitrosylation: specificity, occupancy, and interaction with other post-translational modifications,” Antioxidants & Redox Signaling, vol. 19, pp. 1209–1219, 2013. View at Google Scholar
  136. G. Tong, A. M. Aponte, M. J. Kohr, C. Steenbergen, E. Murphy, and J. Sun, “Postconditioning leads to an increase in protein S-nitrosylation,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 6, pp. H825–H832, 2014. View at Google Scholar
  137. M. J. Kohr, A. M. Evangelista, M. Ferlito, C. Steenbergen, and E. Murphy, “S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death,” Journal of Molecular and Cellular Cardiology, vol. 69, pp. 67–74, 2014. View at Google Scholar
  138. X. Yang, M. V. Cohen, and J. M. Downey, “Mechanism of cardioprotection by early ischemic preconditioning,” Cardiovascular Drugs and Therapy, vol. 24, no. 3, pp. 225–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. L. Yan, S. Yang, H. Shu, L. Prokai, and M. J. Forster, “Histochemial staining and qualification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE,” Electrophoresis, vol. 28, no. 7, pp. 1036–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. E. R. Taylor, F. Hurrell, R. J. Shannon, T. Lin, J. Hirst, and M. P. Murphy, “Reversible glutathionylation of complex I increases mitochondrial superoxide formation,” The Journal of Biological Chemistry, vol. 278, no. 22, pp. 19603–19610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  141. B. Andrews, J. Carroll, S. Ding, I. M. Fearnley, and J. E. Walker, “Assembly factors for the membrane arm of human complex I,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, pp. 18934–18939, 2013. View at Google Scholar
  142. J. Hirst, “Mitochondrial complex I,” Annual Review of Biochemistry, vol. 82, pp. 551–575, 2013. View at Google Scholar
  143. M. A. Moro, A. Almeida, J. P. Bolaños, and I. Lizasoain, “Mitochondrial respiratory chain and free radical generation in stroke,” Free Radical Biology and Medicine, vol. 39, no. 10, pp. 1291–1304, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. E. Fassone and S. Rahman, “Complex I deficiency: clinical features, biochemistry and molecular genetics,” Journal of Medical Genetics, vol. 49, pp. 578–590, 2012. View at Google Scholar
  145. A. H. V. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial Complex I deficiency in Parkinson's disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Google Scholar · View at Scopus
  146. E. T. Chouchani, C. Methner, S. M. Nadtochiy et al., “Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I,” Nature Medicine, vol. 19, pp. 753–759, 2013. View at Google Scholar
  147. C. S. F. Queiroga, A. S. Almeida, C. Martel, C. Brenner, P. M. Alves, and H. L. A. Vieira, “Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis,” The Journal of Biological Chemistry, vol. 285, no. 22, pp. 17077–17088, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. L. Yan, E. S. Christians, L. Liu, X. Xiao, R. S. Sohal, and I. J. Benjamin, “Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage,” The EMBO Journal, vol. 21, no. 19, pp. 5164–5172, 2002. View at Publisher · View at Google Scholar · View at Scopus
  149. G. Sánchez, Z. Pedrozo, R. J. Domenech, C. Hidalgo, and P. Donoso, “Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle,” Journal of Molecular and Cellular Cardiology, vol. 39, no. 6, pp. 982–991, 2005. View at Publisher · View at Google Scholar · View at Scopus
  150. G. Sánchez, M. Escobar, Z. Pedrozo et al., “Exercise and tachycardia increase NADPH oxidase and ryanodine receptor-2 activity: possible role in cardioprotection,” Cardiovascular Research, vol. 77, no. 2, pp. 380–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  151. W. Li, J. Zhang, and W. An, “The conserved CXXC motif of hepatic stimulator substance is essential for its role in mitochondrial protection in H2O2-induced cell apoptosis,” FEBS Letters, vol. 584, no. 18, pp. 3929–3935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. Z. Guo, S. Kozlov, M. F. Lavin, M. D. Person, and T. T. Paull, “ATM activation by oxidative stress,” Science, vol. 330, no. 6003, pp. 517–521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. Y. Shimizu and L. M. Hendershot, “Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species,” Antioxidants and Redox Signaling, vol. 11, no. 9, pp. 2317–2331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  154. P. Ghezzi, “Oxidoreduction of protein thiols in redox regulation,” Biochemical Society Transactions, vol. 33, no. 6, pp. 1378–1381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  155. C. A. O'Brian and F. Chu, “Post-translational disulfide modifications in cell signaling—role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission,” Free Radical Research, vol. 39, no. 5, pp. 471–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  156. S. Fourquet, R. Guerois, D. Biard, and M. B. Toledano, “Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation,” The Journal of Biological Chemistry, vol. 285, no. 11, pp. 8463–8471, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. A. Alfieri, S. Srivastava, R. C. M. Siow, M. Modo, P. A. Fraser, and G. E. Mann, “Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke,” The Journal of Physiology, vol. 589, no. 17, pp. 4125–4136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  158. M. O. Leonard, N. E. Kieran, K. Howell et al., “Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury,” The FASEB Journal, vol. 20, no. 14, pp. 2624–2626, 2006. View at Publisher · View at Google Scholar · View at Scopus
  159. K. Umemura, T. Itoh, N. Hamada et al., “Preconditioning by sesquiterpene lactone enhances H2O2-induced Nrf2/ARE activation,” Biochemical and Biophysical Research Communications, vol. 368, no. 4, pp. 948–954, 2008. View at Publisher · View at Google Scholar · View at Scopus
  160. K. F. Bell, B. Al-Mubarak, J. H. Fowler et al., “Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. E1–E4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. K. F. S. Bell, J. H. Fowler, B. Al-Mubarak, K. Horsburgh, and G. E. Hardingham, “Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 689524, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. W. C. Li, R. Jiang, D. M. Jiang et al., “Lipopolysaccharide preconditioning attenuates apoptotic processes and improves neuropathologic changes after spinal cord injury in rats,” International Journal of Neuroscience. In press.
  163. J. W. Thompson, S. V. Narayanan, and M. A. Perez-Pinzon, “Redox signaling pathways involved in neuronal ischemic preconditioning,” Current Neuropharmacology, vol. 10, pp. 354–369, 2012. View at Google Scholar
  164. X. S. Huang, H. P. Chen, H. H. Yu, Y. F. Yan, Z. P. Liao, and Q. R. Huang, “Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for hypoxic preconditioning-mediated delayed cardioprotection,” Molecular and Cellular Biochemistry, vol. 385, pp. 33–41, 2014. View at Google Scholar
  165. A. Alfieri, S. Srivastava, R. C. Siow et al., “Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke,” Free Radical Biology and Medicine, vol. 65, pp. 1012–1022, 2013. View at Google Scholar
  166. C. Guo, F. Liang, W. Shah Masood, and X. Yan, “Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-kappaB dependent anti-inflammation pathway,” European Journal of Pharmacology, vol. 725, pp. 70–78, 2014. View at Google Scholar
  167. A. K. Jaiswal, “Nrf2 signaling in coordinated activation of antioxidant gene expression,” Free Radical Biology and Medicine, vol. 36, no. 10, pp. 1199–1207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  168. L. Baird and A. T. Dinkova-Kostova, “The cytoprotective role of the Keap1-Nrf2 pathway,” Archives of Toxicology, vol. 85, no. 4, pp. 241–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. E. Kansanen, S. M. Kuosmanen, H. Leinonen, and A. L. Levonen, “The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer,” Redox Biology, vol. 1, pp. 45–49, 2013. View at Google Scholar
  170. L. M. Shelton, B. K. Park, and I. M. Copple, “Role of Nrf2 in protection against acute kidney injury,” Kidney International, vol. 84, pp. 1090–1095, 2013. View at Google Scholar
  171. T. Suzuki, H. Motohashi, and M. Yamamoto, “Toward clinical application of the Keap1-Nrf2 pathway,” Trends in Pharmacological Sciences, vol. 34, pp. 340–346, 2013. View at Google Scholar
  172. T. Ishii, O. Sunami, H. Nakajima, H. Nishio, T. Takeuchi, and F. Hata, “Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide,” Biochemical Pharmacology, vol. 58, no. 1, pp. 133–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  173. M. D. Percival, M. Ouellet, C. Campagnolo, D. Claveau, and C. Li, “Inhibition of cathepsin K by nitric oxide donors: evidence for the formation of mixed disulfides and a sulfenic acid,” Biochemistry, vol. 38, no. 41, pp. 13574–13583, 1999. View at Publisher · View at Google Scholar · View at Scopus
  174. K. K. Chung, “Say NO to neurodegeneration: role of S-nitrosylation in neurodegenerative disorders,” NeuroSignals, vol. 15, no. 6, pp. 307–313, 2006. View at Google Scholar · View at Scopus
  175. J. Tian, S. F. Kim, L. Hester, and S. H. Snyder, “S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10537–10540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  176. E. R. Stadtman, “Protein oxidation and aging,” Science, vol. 257, no. 5074, pp. 1220–1224, 1992. View at Google Scholar · View at Scopus
  177. E. R. Stadtman, “Protein oxidation in aging and age-related diseases,” Annals of the New York Academy of Sciences, vol. 928, pp. 22–38, 2001. View at Google Scholar · View at Scopus
  178. E. R. Stadtman, “Protein oxidation and aging,” Free Radical Research, vol. 40, no. 12, pp. 1250–1258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  179. E. R. Stadtman and R. L. Levine, “Free radical-mediated oxidation of free amino acids and amino acid residues in proteins,” Amino Acids, vol. 25, no. 3-4, pp. 207–218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. T. J. Jönsson, M. S. Murray, L. C. Johnson, and W. T. Lowther, “Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate,” The Journal of Biological Chemistry, vol. 283, no. 35, pp. 23846–23851, 2008. View at Publisher · View at Google Scholar · View at Scopus
  181. T. J. Jönsson, A. W. Tsang, W. T. Lowther, and C. M. Furdui, “Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin,” The Journal of Biological Chemistry, vol. 283, no. 34, pp. 22890–22894, 2008. View at Publisher · View at Google Scholar · View at Scopus